HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

Executive Summary

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

You may also be interested in...



EU To Provide Guidance On New Endocrine Disruptor, Persistent Chemicals Hazard Classes In 2024

Industry should use existing guidance for the identification of endocrine disruptors until the European Chemicals Agency updates Guidance on the Application of the CLP Criteria, targeted for mid-2024. Transition periods will begin elapsing in May 2025 when new substances on the market must be compliant with the new hazard communication requirements, followed by new mixtures in May 2026.

‘The Party Is Over': Green Claims Requirements Among Many Regulatory Changes Coming To EU Cosmetics

Biorius CEO Frédéric Lebreux provided updates on EU Green Deal initiatives including revision of the Cosmetic Products Regulation, as well as regulations in development for green claims and ecodesign, at the Independent Beauty Association’s virtual Technical/Regulatory Forum.

EU Reg Consultant On CLP Revisions: Take A Breath, Cost It Out, Consider ‘Lobbying And Pushing Back’

Louise Witter of UK-based Chemical Legislation Professionals spoke with HBW Insight ahead of the European Commission’s 19 December adoption of a proposal to revise the CLP by introducing new hazard classes, including for endocrine disruptors.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel